← Back to Clinical Trials
Recruiting NCT02456974

Antibiotic Dosing in Pediatric Intensive Care

Trial Parameters

Condition Pharmacokinetics
Sponsor University Hospital, Ghent
Study Type OBSERVATIONAL
Phase N/A
Enrollment 640
Sex ALL
Min Age 1 Day
Max Age 16 Years
Start Date 2012-05
Completion 2027-09-01
Interventions
blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical careblood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.blood sampling in patients receiving vancomycin as part of routine clinical care.

Brief Summary

Pharmacokinetics of antibiotics in critically ill neonates, infants and children

Eligibility Criteria

Inclusion Criteria: * patients admitted to the pediatric intensive care unit * patient age/weight : 1,8 kg-15 years * patient receiving antibiotic treatment (piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, teicoplanin, meropenem, ciprofloxacin, amikacin) via intermittent infusion regimen or continuous infusion according to institutional treatment guidelines * intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred) Exclusion Criteria: * no catheter in place for blood sampling * absence of parental/patient consent * known hypersensitivity to beta-lactam antibiotics, glycopeptides, fluoroquinolones, aminoglycosides * extracorporeal circuit (haemodialysis, ECMO, peritoneal dialysis )

Related Trials